determining optimal working concentration by titration.
References
1. Yang, A., et al., Mol. Cell, 2, 305-316 (1998).
2. Chen, X., Mol. Med. Today, 5, 387-392 (1999).
3. Levrero, M., et al., Cell Death Differ
determining optimal working concentration by titration.
References
1. Yang, A., et al., Mol. Cell, 2, 305-316 (1998).
2. Yang, A., et al., Nature, 398, 714-718 (1999).
3. Signoretti, S., et al., Am. J. Pathol
D31P30BR 30 kg 5 g 355 x 305 mm 80250485 312
D31P30BR-M 30 kg 10 g 355 x 305 mm 80250491 370
D31P60BR 60 kg 10 g 355 x 305 mm 80250486 312
D31P60BR-M 60 kg 20 g 355 x 305 mm 80250492
Danieli, et al., Helv. Chim. Acta, 1997, 80, 1153.
65 S. Riva, et al., Carbohydrate Research,1998, 305, 525.
66 B. Danieli, et al., J. Org. Chem., 2001, 66, 262.
67 S. Gebhard, et al.
Biomaterials 26, 971–977.
37. Lian, J. B. & Stein, G. S. (1992) Crit. Rev. Oral Biol. Med. 3, 269–305.
38. Holtorf, H. L., Datta, N., Jansen, J. A. & Mikos, A. G. (2005) J. Biomed. Mater.
Res. A 74
CN¯ Certipur® 119533 203
D Decalcification solution base: citric acid about 19 % 100240 280
Desiccant sachet 10 g silica gel with humidity indicator (orange gel) sachet: 7 x 9 cm 103804 266
Desiccant
monocyte chemoattractant protein-1 in healthy and critically ill
dogs. Vet Clin Pathol 2010; 39: 302–305.
30. Olsson M, Frankowiack M, Tengvall K et al. The dog as a genetic
model for immunoglobulin A
multielementos VII para cromatografía catiónica (9 elementos en HNO3 0,001 mol/l)100 mg/l:
NH4, Ba, Ca, K, Li, Na, Mg, Mn, Sr Certipur®
110322 203
Patrón multielemento I disuelto en aceite c(Ba
Cancer 5, 275 .
Weissman, I . 2005 . JAMA 294, 1359 .
Christopherson, K .W . et al . 2004 . Science 305, 1000 .
Ding, S ., and Schultz, P .G . 2004 . Nat. Biotech. 22, 833 .
Fu, M .
to injury or neurodegenerative diseases.
References:
Christopherson, K.W. et al. 2004. Science 305, 1000.
Ding, S., and Schultz, P.G. 2004. Nat. Biotechnol. 22, 833.
Fu, M., et al. 2004. J. Cell Biol
M NP_005304.3 y y n/d
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 2931 GSK3A M NP_063937.2 y y y
305 Glycogen Synthase Kinase-3? (GSK-3?) G7914 2932 GSK3B P NP_001139628.1,NP_002084.2 y n/d y
307 Glycogen
M NP_005304.3 y y n/d
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 2931 GSK3A M NP_063937.2 y y y
305 Glycogen Synthase Kinase-3? (GSK-3?) G7914 2932 GSK3B P NP_001139628.1,NP_002084.2 y n/d y
307 Glycogen
M NP_005304.3 y y n/d
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 2931 GSK3A M NP_063937.2 y y y
305 Glycogen Synthase Kinase-3? (GSK-3?) G7914 2932 GSK3B P NP_001139628.1,NP_002084.2 y n/d y
307 Glycogen
:
Takashima, S. 2009. Circulation J. 7, 208.
Gao, Y. et al. 2003. Biochem Biophys. Res. Commun. 305, 16.
Kamm, K.E., and Stull, J.T. 2001. J. Biol. Chem. 276, 4527.
Hatch, V., et al. 2001. J. Cell Biol
G6670 M y y y
303 Glutamate receptor NMDAR 2a G9038 P y y y
304 Glutamine Syntethase G2781 P n/d n/d y
305 Glycogen Synthase Kinase-3β (GSK-3β) G7914 P y n/d y
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 M
16.04.07 9:52
Date 16.04.2007
Time 9:52:09
OK
Date/Time 16.04.07 9:52
Date 16.04.2007
Time 9:52:09
OK
Date
23 .10.2006
Date/Time 16.04.07 9:52
Date 16.04.2007
Time 9:52:09